Literature DB >> 6298370

Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests.

P Leinikki, I Shekarchi, M Iivanainen, E Taskinen, K V Holmes, D Madden, J L Sever.   

Abstract

The enzyme-linked immunosorbent assay (ELISA) was used to determine levels of specific IgG antibodies against measles, rubella, vaccinia, corona (OC43) and mumps viruses in cerebrospinal fluid (CSF) and serum of 18 patients with clinically definite multiple sclerosis (MS), 8 patients with optic neuritis (ON), 27 patients with other neurological disease (OND), and 88 control subjects without central nervous system disease. Serum antibody levels were not significantly different between the four groups. Differences in the frequency and levels of CSF antibodies between the four groups were observed. Control patients had serum/CSF antibody ratios from 2.0 to 3.0 (log) with an average of 2.5 corresponding to a 320-fold difference between serum and CSF antibody levels. MS patients had ratios from 1.1 to 2.1 with an average of 1.6. The average was 2.0 for the ON patients. The average for the OND patients was similar to the controls. The altered serum/CSF ratios for several viruses within an individual patient was similar. These results suggest that nonspecific immunostimulation is responsible for the increased levels of CSF virus antibodies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6298370      PMCID: PMC7127299          DOI: 10.1016/0022-510x(82)90031-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  [Studies with gamma globulin labeled with radioiodine on the origin of protein bodies in the cerebrospinal fluid].

Authors:  E FRICK; L SCHEID-SEYDEL
Journal:  Klin Wochenschr       Date:  1958-09-15

Review 3.  Significance of virus antibodies in multiple sclerosis.

Authors:  M Haire
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples.

Authors:  P O Leinikki; I Shekarchi; P Dorsett; J L Sever
Journal:  J Clin Microbiol       Date:  1978-10       Impact factor: 5.948

5.  Evaluation of enzyme-linked immunosorbent assay (ELISA) for mumps virus antibodies.

Authors:  P O Leinikki; I Shekarchi; N Tzan; D L Madden; J L Sever
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

6.  Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

Authors:  H Link
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

7.  Solid phase antibody assay by means of enzyme conjugated to anti-immunoglobulin.

Authors:  P Leinikki; S Pässilä
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

8.  CSF oligoclonal bands, immunoglobulins, and viral antibodies in progressive myoclonus epilepsy.

Authors:  M Iivanainen; P Leinikki; E Taskinen; I C Shekarchi; D Madden; J Sever
Journal:  Arch Neurol       Date:  1981-04

9.  Viral antibodies in multiple sclerosis.

Authors:  E Norrby
Journal:  Prog Med Virol       Date:  1978

10.  Multiple sclerosis: correlation between immunoglobulin-G in cerebrospinal fluid and brain.

Authors:  W W Tourtellotte; J A Parker
Journal:  Science       Date:  1966-11-25       Impact factor: 47.728

View more
  3 in total

1.  Demonstration of intraocular synthesis of immunoglobulin G toxoplasma antibodies for specific diagnosis of toxoplasmic chorioretinitis by enzyme immunoassay.

Authors:  H J Turunen; P O Leinikki; K M Saari
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

Review 2.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

3.  SJL mice infected with Acanthamoeba castellanii develop central nervous system autoimmunity through the generation of cross-reactive T cells for myelin antigens.

Authors:  Chandirasegaran Massilamany; Francine Marciano-Cabral; Bruno da Rocha-Azevedo; Melissa Jamerson; Arunakumar Gangaplara; David Steffen; Rana Zabad; Zsolt Illes; Raymond A Sobel; Jay Reddy
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.